Prices of major drugs for treating cancer, diabetes and blood pressure cut by 25%

Products of major pharmaceutical firms, including Abbott Healthcare, Cipla and Lupin will be affected by the new price cap

Read More
Publication Date: 
07/06/2016
Business Standard (New Delhi)
Tags:
Drugs, Cancer, Hypertension (Blood Pressure), Diabetes, Drug Industry, Health Care, Health